Related Experiment Videos
Application of spectroscopic imaging in epilepsy
1Department of Neurology, University of California, San Francisco 94143, USA.
Magnetic Resonance Imaging
|January 1, 1995
Summary
Magnetic Resonance Spectroscopy (MRS) reveals metabolic abnormalities in the brain, aiding in the localization of seizure foci for epilepsy surgery. These findings improve patient selection and surgical outcomes.
Area of Science:
- Neuroscience
- Medical Imaging
- Biochemistry
Background:
- Functional and anatomical neuroimaging significantly impacts the evaluation of patients for epilepsy surgery.
- Positron Emission Tomography (PET) demonstrated interictal metabolic abnormalities in the epileptogenic focus, increasing surgical candidacy and reducing the need for invasive intracranial electrode evaluations.
Purpose of the Study:
- To evaluate the utility of Magnetic Resonance Spectroscopy (MRS) in identifying and localizing seizure foci.
- To correlate metabolic changes detected by MRS with epilepsy localization and severity.
Main Methods:
- Utilized single voxel and whole brain 1H and 31P MRS imaging techniques.
- Analyzed metabolic changes including inorganic phosphate (Pi), pH, phosphomonoesters (PME), and N-acetylaspartate (NAA).
- Correlated MRS findings with anatomical measures like hippocampal atrophy and cell loss.
Main Results:
- Interictal MRS showed characteristic metabolic changes: increased Pi, elevated pH, and decreased PME and NAA in the epileptogenic focus.
- MRS accurately lateralized temporal and frontal lobe epilepsy.
- Decreased NAA concentrations correlated with cell loss severity and may indicate the seizure onset zone, even when changes are widespread.
Conclusions:
- MRS detects abnormal metabolic activity and asymmetry patterns in focal epilepsy, useful for seizure localization.
- Metabolic findings from MRS can guide patient selection for epilepsy surgery and potentially reduce the need for invasive monitoring.
- MRS offers a non-invasive method to assess metabolic dysfunction associated with epilepsy.